Benchmarking Danish pharma
We benchmarked the accountability performance of Danish pharmaceutical multinational Novo Nordisk in 2006.
We used our Accountability Rating methodology to assess the company across a wide range of criteria, and drew on data from our annual application of the Rating to the world’s largest companies to compare its performance with leaders in accountability and its peers. The resulting report provided Novo Nordisk with a comprehensive picture of how it measured up in each of the six domains of the Rating. We also recommended ways it could improve its accountability, backed up by examples of best practice. Our report included a detailed analysis of Novo Nordisk’s strategy and policies.
